|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 1/22 | |
| C07K 14/745 | |||
| C12N 9/64 |
| (11) | Number of the document | 2526115 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11700547.0 |
| Date of filing the European patent application | 2011-01-18 | |
| (97) | Date of publication of the European application | 2012-11-28 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/050594 |
| Date | 2011-01-18 |
| (87) | Number | WO 2011/086197 |
| Date | 2011-07-21 |
| (30) | Number | Date | Country code |
| 297011 P | 2010-01-21 | US | |
| 10150980 | 2010-01-18 | EP |
| (72) |
BJELKE, Jais, Rose, DK
|
| (73) |
Novo Nordisk Health Care AG,
Andreasstrasse 15, 8050 Zürich,
CH
|
| (54) | PURIFICATION OF BLOOD COAGULATION FACTORS |
| PURIFICATION OF BLOOD COAGULATION FACTORS |